Parth Sharma

Hem-Onc fellow @VCUHealth @VCUMassey via IM Resident @umkcIM, UG @aiims_newdelhi & former research trainee @theNCI
Passionate about Global Oncology

[Parth Sharma @ParthDSharma]

Had an amazing few days at #ASCO2026! 🎉 Proud to present our research poster 📊, energized by the latest advances in cancer research 🔬, and grateful for the chance to reconnect with friends 🤝 and spend time with mentors who have influenced my journey 🙏. The science was exceptional, but the people made it even more special! ✨
@VCUMassey @VCUHealth
@zweigle_joshua

[Parth Sharma @ParthDSharma]

Had a wonderful time presenting our research highlighting the efficacy of #immunecheckpointinhibitors in advanced lung LCNEC at #ASCO25.

Grateful to my mentor @anuj_shrestha11 for his guidance and to the co-authors for their support.

@ASCO @umkcIM
@KrityaMangesh

[Marc Roth @MarcRothMD]

#ASCO25 Day 2: so proud of our two stellar residents, soon to be fellows! @Meddoc77 (Himil Mahadevia) and Parth Sharma. Congrats on the posters, can’t wait to see what your futures hold! @SLCI_KC @saintlukeskc

[Parth Sharma @ParthDSharma]

Thrilled to present our research at the #NCCN2025!!
Grateful to my mentor for his guidance and the co-authors for their support.

@umkcIM @anuj_shrestha11
@PiyushNathani3 @Rohit_nathani1
@NCCN

[OncoDaily GI @OncoDailyGI]

The efficacy of HER-2 targeted therapies in biliary tract cancers - @ParthDSharma
@ASCO

https://t.co/jeNi7dQwz4

#Cancer #GIOnc #GI25 #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

[Parth Sharma @ParthDSharma]

@sciqst Thank you!!!
Our study found that HER-2 targeted MOAs, ADCs, and bispecific antibodies have demonstrated promising results in BTCs.

[Parth Sharma @ParthDSharma]

Thrilled to present our research at @ASCO #GI25 highlighting the efficacy of HER-2 targeted therapies in #biliarytractcancers!!!

Grateful to my mentor @MarcRothMD for his guidance and all the co-authors for their support.

@KrityaMangesh
@umkcIM @SLCI_KC
#MedTwitter

[Himil Mahadevia @Meddoc77]

Happy to share our literature review on current and upcoming pharmacologic drugs for Sickle cell disease published in Annals of Hematology - https://t.co/EAKHFqL6GI

@umkcIM @BPonvilawan @Ujjwal_Madan1 @ParthDSharma @anuj_shrestha11

#Hematology #HemeTwitter #MedTwitter #MedEd

[Parth Sharma @ParthDSharma]

@BPonvilawan @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you!!!

[Parth Sharma @ParthDSharma]

Dreams do come true!!! Matched to the Hem-Onc fellowship at @VCUHealth, one of the NCI-designated comprehensive cancer centers.

Grateful to my wife @Priyanka031996, family, friends, and mentors at @umkcIM, @SLCI_KC, and @aiims_newdelhi.

@VCUMassey
#Match2025 @HemOncFellows #GlobalOncology

[Parth Sharma @ParthDSharma]

@docs4accidents @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you!!!

[Parth Sharma @ParthDSharma]

@UGrewalMD @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you!!!

[Parth Sharma @ParthDSharma]

@Samiksh34455308 @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you!!!

[Parth Sharma @ParthDSharma]

@OncologyIntel @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you!!!

[Parth Sharma @ParthDSharma]

@oyster_doctor @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you!!

[Parth Sharma @ParthDSharma]

@e_toro123 @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you!!

[Parth Sharma @ParthDSharma]

@ifrahfatima @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you Ifrah!!

[Parth Sharma @ParthDSharma]

@AlsakarnehSaqr @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you!

[Parth Sharma @ParthDSharma]

@IslamHassanM @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you Islam! You guys have been a great support in this journey